Ret Proto-Oncogene (RET) Peptide
RET
Hôte: Synthetic
BP, WB, IHC
-
- Antigène Tous les produits Ret Proto-Oncogene (RET)
- Ret Proto-Oncogene (RET)
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Fonction
- Ret (extracellular) Negative Control Antigen
- Séquence
- CEWRQGDGKG ITR, correspond ing to amino acid residues 541-553 of human Ret (Accession P07949).
- Attributs du produit
- Synthetic peptide, A Blocking peptide for Anti-Ret (extracellular) Antibody (ABIN7043600, ABIN7044783 and ABIN7044784)). Intended to be used as a negative control.
- Pureté
- >70 %
-
-
- Indications d'application
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
- Commentaires
-
Confirmed by amino acid analysis and mass spectrometry.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- 100 μL double distilled water (DDW).
- Stock
- RT,-20 °C
- Stockage commentaire
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
- Antigène
- Ret Proto-Oncogene (RET)
- Synonymes
- c-ret Peptide, cret Peptide, etID315074.13 Peptide, ret1 Peptide, wu:fd13h01 Peptide, X-ret Peptide, ret-A Peptide, xret Peptide, RET Peptide, MTC1 Peptide, CDHF12 Peptide, CDHR16 Peptide, HSCR1 Peptide, MEN2A Peptide, MEN2B Peptide, PTC Peptide, RET-ELE1 Peptide, RET51 Peptide, RET9 Peptide, c-Ret Peptide, ret proto-oncogene receptor tyrosine kinase Peptide, ret proto-oncogene S homeolog Peptide, ret proto-oncogene Peptide, ret Peptide, ret.S Peptide, RET Peptide, Ret Peptide
- ID gène
- 5979
- NCBI Accession
- NM_020975
- UniProt
- P07949
-
Vous êtes ici:
